A candidate molecular biomarker panel for the detection of bladder cancer.
about
Analysis of the transcriptome in molecular epidemiology studiesA Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.Multiplex protein signature for the detection of bladder cancer in voided urine samplesMatrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulationExternal validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.Simultaneous multi-analyte urinary protein assay for bladder cancer detectionValidation and clinicopathologic associations of a urine-based bladder cancer biomarker signature.Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.Urinary protein biomarker panel for the detection of recurrent bladder cancerAngiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.A multiplex immunoassay for the non-invasive detection of bladder cancerBladder cancer detection and monitoring: assessment of urine- and blood-based marker testsUrinary mRNA biomarker panel for the detection of urothelial carcinoma.IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System.A microRNA biomarker panel for the non-invasive detection of bladder cancer.Urinary biomarkers of bladder cancer: an update and future perspectives.MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS.Circulating microRNA biomarkers for glioma and predicting response to therapy.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.Developing proteomic biomarkers for bladder cancer: towards clinical application.Molecular markers in bladder cancer: Novel research frontiers.Signaling pathways activation profiles make better markers of cancer than expression of individual genes.Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway.The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and MonitoringValidation of Urine-based Gene Classifiers for Detecting Bladder Cancer in a Chinese Study
P2860
Q28817795-72613EA4-CEAF-4DF9-A3AF-5F850B4BDD1CQ31112817-9ADADE20-24D8-48FA-B5ED-D3D0A9E6C66EQ33581322-2CF49894-9E10-4DA3-9FD8-CC8350A91453Q33619919-BAA36843-D1EE-4C79-831D-E6BBD88533DFQ33782164-E15CF3AD-E30A-4464-A407-819B375E6809Q34135237-2141F96D-9634-4B21-B8E6-405F5E04420FQ34502450-EABE78F1-370D-45ED-846A-3414C1CEFFDBQ34579038-CDA4BDB2-49B7-4542-B0A9-DECDA8C73093Q35050111-391172D2-33CD-4F04-9FF8-A6CDEE1B731FQ35050119-57847A2A-AA74-4270-BD4F-5EF685CB5F2DQ35050128-41309C05-B3AF-4705-8A04-B1D9D83A69D9Q36375193-E9BB9F8C-668A-401D-9009-4B393265770AQ36531228-271C043E-606B-4EE6-850C-F14733C8A63EQ36770389-FA40E222-6270-47A6-9806-2E2F604896E4Q37437646-3255DCA6-34C3-4153-98D6-C2D12927DB33Q37685419-0EBC0A72-1C54-487B-87D2-FDD8DA69D679Q37699233-DA67DDF9-EB86-48D7-A42A-A57A583F73A5Q38138607-82A547F9-D2D5-4B7B-BFDD-4CD0BF846149Q38188561-A1AE74AF-4A05-49D6-8A89-16CE02F64238Q38201683-DEEF239E-E8D7-442C-A83B-CD690BA0310BQ38216129-560A2D2B-10CA-4757-8927-AFC18EBDC0F8Q38396110-FBC06554-F8AB-4192-A025-DC7A8882C805Q38511509-D9989832-F89B-458D-BB2A-FA6EFDD71964Q38520403-DDC92357-1329-4454-BB3D-0341A2EA6C4CQ41874902-9BEB53F2-BC48-49DF-B6A0-C0512753B880Q47120808-BA13F271-8DC6-4D70-A3C9-92F1F5234D7BQ47826917-26CC2C6C-E4E0-4550-B68B-84E26E83ABF0Q50256258-7938608B-3360-4760-8820-DE9EECC3FA97Q52718423-CF186CAC-2B08-445D-BEF4-1593EDBC5802Q55072176-2D52767D-A491-4619-8C4A-733A947BCB5EQ58704141-D4027097-978C-4773-BE81-6AB1B2CA04EAQ58798340-06E56718-4D78-4065-8902-596C1DFD2BFE
P2860
A candidate molecular biomarker panel for the detection of bladder cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A candidate molecular biomarker panel for the detection of bladder cancer.
@ast
A candidate molecular biomarker panel for the detection of bladder cancer.
@en
type
label
A candidate molecular biomarker panel for the detection of bladder cancer.
@ast
A candidate molecular biomarker panel for the detection of bladder cancer.
@en
prefLabel
A candidate molecular biomarker panel for the detection of bladder cancer.
@ast
A candidate molecular biomarker panel for the detection of bladder cancer.
@en
P2093
P2860
P1476
A candidate molecular biomarker panel for the detection of bladder cancer.
@en
P2093
Charles J Rosser
Steve Goodison
Virginia Urquidi
Yunpeng Cai
P2860
P304
P356
10.1158/1055-9965.EPI-12-0428
P577
2012-10-24T00:00:00Z